Shows
Genetics for HealthcareHealing Beyond Medicine: Where DNA Discoveries and Patient Hearts Align | Dr. Chadi NabhanThis is GENETICS FOR HEALTHCARE—a podcast dedicated to helping patients and caregivers advocate for precision medicine in treatment, survivorship, disease screening, and prevention. #geneticsforhealthcareIn this deeply personal episode oncologist and author Dr. Chadi Nabhan joins host Rome Madison for a conversation that bridges cutting-edge science with timeless human connection. Dr. Nabhan shares the pivotal moment that defined his career—a dying patient's simple request: "Just promise you'll come back tomorrow and smile." This encounter revealed medicine's profound truth: while genetics and AI are revolutionizing cancer treatment (like his work accelerating clinical trials through AI at Righ...2025-05-0853 min
Health Coach Talk: Conversations About Wellness Through Functional Medicine CoachingRoot Cause And Cancer, With Dr. Chadi NabhanWhat role do environmental toxins play in chronic disease, and how can we foster hope and resilience in cancer care? In this episode of Health Coach Talk, Dr. Sandi is joined by Dr. Chadi Nabhan, a distinguished oncologist, author, and advocate, to explore these critical questions. Together, they discuss his groundbreaking work linking glyphosate to cancer, his experiences during the Monsanto litigation trials, and his commitment to empowering patients and caregivers with knowledge and support.
Show notes: https://functionalmedicinecoaching.org/podcast/chadi-nabhan-113/2025-01-1626 min
Talking To Teens: Expert Tips for Parenting TeenagersEp 316: Educating Teens About CancerChadi Nabhan, author of The Cancer Journey, joins us to discuss how parents can talk to their teenagers about cancer, understand the common misconceptions, and best support teens when their peers or family members face a cancer diagnosis.Full Show NotesCancer is a challenging topic for families to discuss, especially when teenagers are involved. The fear, confusion, and misinformation surrounding cancer can make these conversations even more daunting. At some point, your teen might encounter a peer, teacher, or friend's family dealing with a cancer journey, and knowing how to communicate...2024-11-2522 min
Up For A ChatUC 405: The Cancer Journey With Dr Chadi NabhanCyndi and Kim sit down with Dr. Chadi Nabhan again, a renowned oncologist and hematologist with over 20 years of experience, to discuss his latest book, The Cancer Journey. Dr. Nabhan shares his motivation for writing the book: to offer guidance and support to patients and families navigating the complexities of cancer.
The conversation delves into the power of storytelling as a tool to simplify cancer-related topics, making them more accessible and relatable. Together, they explore key aspects of cancer, including its definition, causes, prevention, and the variety of treatment options available today.
Dr. Nabhan highlights...2024-11-211h 13
Mind Body Health & PoliticsWhat Every Patient Needs to Know About Cancer Detection - with Dr. Chadi NabhanCan a simple ultrasound save your life when mammograms miss the mark? Should you get a colonoscopy every year, or is that too extreme? In my latest interview with distinguished hematologist-oncologist Dr. Chadi Nabhan, author of over 300 medical articles and abstracts, we dive deep into the complex world of cancer screening, prevention, and treatment."Cancer is not one disease," Dr. Nabhan emphasizes. "Many cancers are curable, while some are not. They're not equal, and we can't treat them all the same way."In this episode Dr. Miller engages with Dr. Chadi Nabhan, a distinguished hematologist and oncologist...2024-11-091h 05
Access Must-Have Full Audiobooks in Health & Wellness, Disorders & DiseasesThe Cancer Journey: Understanding Diagnosis, Treatment, Recovery, and Prevention by Chadi Nabhan Md Mba FacpPlease visithttps://thebookvoice.com/podcasts/1/audiobook/782987to listen full audiobooks.
Title: The Cancer Journey: Understanding Diagnosis, Treatment, Recovery, and Prevention
Author: Chadi Nabhan Md Mba Facp
Narrator: Chadi Nabhan Md Mba Facp
Format: Unabridged Audiobook
Length: 11 hours 49 minutes
Release date: October 15, 2024
Genres: Disorders & Diseases
Publisher's Summary:
A compassionate guide to the cancer journey, from screening and prevention to diagnosis and recovery.A cancer diagnosis can change our lives and the lives of our loved ones in an instant. It leaves us seeking answers to myriad questions and searching for hope. In The Cancer Journey, Dr. Chadi Nabhan demystifies this complex...2024-10-1511h 49Explore the Latest Full Audiobooks in Health & Wellness, Medicine & NaturopathyThe Cancer Journey: Understanding Diagnosis, Treatment, Recovery, and Prevention by Chadi Nabhan Md Mba FacpPlease visithttps://thebookvoice.com/podcasts/1/audiobook/782987to listen full audiobooks.
Title: The Cancer Journey: Understanding Diagnosis, Treatment, Recovery, and Prevention
Author: Chadi Nabhan Md Mba Facp
Narrator: Chadi Nabhan Md Mba Facp
Format: Unabridged Audiobook
Length: 11 hours 49 minutes
Release date: October 15, 2024
Genres: Medicine & Naturopathy
Publisher's Summary:
A compassionate guide to the cancer journey, from screening and prevention to diagnosis and recovery.A cancer diagnosis can change our lives and the lives of our loved ones in an instant. It leaves us seeking answers to myriad questions and searching for hope. In The Cancer Journey, Dr. Chadi Nabhan demystifies this complex...2024-10-1511h 49
Integrative Cancer Solutions with Dr. KarlfeldtNavigating the Cancer Journey: Simplifying Treatment, Trials, and Trust with Dr. Chadi NabhanIn this insightful episode, we sit down with Dr. Chadi Nabhan, a renowned medical oncologist and hematologist, to discuss his latest book, The Cancer Journey. Dr. Nabhan’s book aims to simplify complex cancer information, providing patients and families with an accessible guide through the often confusing and overwhelming landscape of cancer care. He covers key areas such as understanding a cancer diagnosis, the various treatment options available, and the pivotal role clinical trials can play in advancing care. Dr. Naban also stresses the importance of open communication between patients and oncologists, the need for trustworthy information in a se...2024-10-0949 min
The ALL NEW Big Wakeup Call with Ryan GatenbyDr. Chadi NabhanSend us a textDr. Chadi Nabhan discusses his book THE CANCER JOURNEY: Understanding Diagnosis, Treatment, Recovery, and Prevention.Chadi Nabhan, MD, MBA, FACP, is a board-certified hematologist and a medical oncologist who practiced hematology and oncology for years. He has authored or co-authored over 300 peer-reviewed manuscripts and abstracts. He is the author of Toxic Exposure: The True Story behind the Monsanto Trials and the Search for Justice and is the creator and host of the weekly Healthcare Unfiltered podcast.2024-09-2712 min
Chris Beat Cancer: Heal With Nutrition & Natural TherapiesDr. Chadi Nabhan - Expert witness against Monsanto in the Roundup cancer trialsShow notes and links: https://www.chrisbeatcancer.com/dr-chadi-nabhan-expert-witness-against-monsanto-in-the-roundup-cancer-trials/2024-06-1954 min
Caris Molecular Minute PodcastsInterview with Dr. Rachna Schroff: Highlights from 2024 ASCO-GIJoin host Dr. Chadi Nabhan and special guest Dr. Rachna Schroff, Chief, Division of Hematology/Oncology and Associate Director of Clinical Investigations at the University of Arizona as they take a deep dive into the latest highlights from this year’s ASCO-GI meeting. Explore novel oncology research, groundbreaking trials, and the transformative role molecular profiling and liquid biopsies are playing in revitalizing the field of gastrointestinal cancer. Don’t miss these essential highlights from this year’s meeting.
For more information, please visit: www.CarisLifeSciences.com2024-02-2127 min
Caris Molecular Minute PodcastsInterview with Dr. Ishwaria Subbiah: Equity in Clinical TrialsUncover the path to equitable clinical trials in the latest Caris Molecular Minute podcast with host Dr. Chadi Nabhan, Chairman of the Caris Precision Oncology Alliance and his guest, Dr. Ishwaria Subbiah, Executive Director at Sarah Cannon Research Institute. Together, they explore ways to enhance patient access and enrollment, mitigate disparities, and foster equality in clinical trials. Don't miss this thought-provoking conversation aimed at reshaping the narrative for a more inclusive and impactful future in cancer care and research.
For more information, please visit: www.CarisLifeSciences.com2024-01-3130 min
Caris Molecular Minute PodcastsInterview with Dr. Ari VanderWalde - Clinical Trials at Caris Life Sciences: The Path ForwardCaris Precision Oncology Alliance Chairman, Dr. Chadi Nabhan, sits down for an engaging podcast interview with Dr. Ari VanderWalde, Global Head of Clinical Trials at Caris Life Sciences. Join them as they delve into the world of clinical trials, exploring the intricacies of clinical research, providing valuable insights into Caris' contributions, and the accessibility of these transformative opportunities.
For more information, please visit: www.CarisLifeSciences.com2024-01-1028 min
Caris Molecular Minute PodcastsInterview with Dr. Emil Lou: Pathogens and Cancer AssociationsJoin Dr. Chadi Nabhan, Chairman of the Caris Precision Oncology Alliance, in a captivating podcast conversation with special guest Dr. Emil Lou, Associate Professor of Medicine at the University of Minnesota. Delve into the intricate connections between pathogens and cancer, exploring both research breakthroughs and the clinical implications. Gain valuable insights into the current landscape and discover what the future holds for this dynamic intersection of science and medicine.
For more information, please visit: www.CarisLifeSciences.com
2023-12-1424 min
Caris Molecular Minute PodcastsInterview with Dr. David Braxton: Molecular Pathology and Precision MedicineCaris Precision Oncology Alliance Chairman, Dr. Chadi Nabhan, sits down for an engaging podcast interview with Dr. David Braxton, Chief of Service for Molecular Pathology at Hoag Hospital in Newport Beach, California. Explore Dr. Braxton's remarkable career as a molecular pathologist and delve into the pivotal role molecular pathologists play in precision oncology, while examining the progressive integration of artificial intelligence within molecular pathology.
For more information, please visit: www.CarisLifeSciences.com2023-11-2929 min
Caris Molecular Minute PodcastsInterview with Dr. Salma Jabbour: Radiation Therapy Simplified
Join Caris Precision Oncology Alliance Chairman, Dr. Chadi Nabhan, sand Dr. Salma Jabbour, Clinical Chief, Radiation Oncology and Vice Chair of Clinical Research & Faculty Development at RWJUH/Rutgers Cancer Institute, as they delve into the depths of radiation therapy in cancer care. Together they’ll unravel the intricacies of this vital treatment option, covering its mechanisms, innovations, and the pivotal role it plays in the journey towards effective oncological treatment for patients.
For more information, please visit: www.CarisLifeSciences.com2023-11-0226 min
Caris Molecular Minute PodcastsInterview with Jeanine Cervoni: Hope, Resilience and HealingCaris Precision Oncology Alliance Chairman, Dr. Chadi Nabhan, sits down with Jeanine Cervoni, Senior Director, Commercial Education at Caris Life Sciences. Join them in this empowering podcast as she shares the strength, resilience and hope that powered her through her personal breast cancer journey.
For more information, please visit: www.CarisLifeSciences.com
2023-10-2523 min
Caris Molecular Minute PodcastsInterview with Dr. George Sledge: A Breast Cancer Specialist's Journey
Caris Precision Oncology Alliance Chairman, Dr. Chadi Nabhan, sits down with Dr. George Sledge, Executive Vice President and Chief Medical Officer at Caris Life Sciences. Together they delve into his inspiring career as a prominent breast cancer specialist, his passion for this field, and his vision for the future of breast cancer care.
For more information, please visit: www.CarisLifeSciences.com
2023-10-1129 min
Up For A ChatUC 378: Toxic Exposure with Chadi NabhanIn this podcast, Chadi Nabhan discusses his new book, TOXIC EXPOSURE: The True Story Behind the Monsanto Trials and the Search for Justice.
Chadi Nabhan, MD, MBA, is a board-certified hematologist and a medical oncologist who practiced oncology and treated lymphoma patients for years. He has over 300 peer-reviewed papers, abstracts, and book chapters. He has worked in diverse healthcare settings and is the creator and host of the Healthcare Unfiltered podcast.
You can find Dr Chadi Nabhan at:
https://chadinabhan.com/
chadi nabhan MD, MBA, FACP (@chadinabhan) / X (twitter.com)
http...2023-09-271h 04
Caris Molecular Minute PodcastsInterview with Dr. Tina Bhatnagar: What's Next in Disparities Research?Caris Precision Oncology Alliance Chairman, Dr. Chadi Nabhan, sits down with Dr. Tina Bhatnagar, Associate Professor, Director of Hematology and Medical Oncology at West Virginia University. Together they discuss disparities research, the types of methodologies used and what can be done to mitigate the disparities seen in practice.
For more information, please visit: www.CarisLifeSciences.com/POA-Intro/
2023-09-2124 min
The Gut Health Gurus PodcastDr Chadi Nabhan on Monsanto Trials :Glyphosate ExposedDr Chadi Nabhan, MD, is an oncologist who has been involved in litigation cases with Monsanto. In this video, we explore glyphosate and his involvement in the Monsato Trials. Remember to Like, Share, and Subscribe for more insightful discussions! Topics Discussed: Who is Dr Chadi Nabhan? Chadi's clinical experience in Oncology Chadi's most memorable Oncology patient story What is Cancer and what causes it? Treatment options and Preventative Measures? Cancers of the Gut Introduction to Monsanto Trial - Round...2023-09-0453 min
Caris Molecular Minute PodcastsInterview with Drs. Charu Aggarwal & Balazs Halmos: Adjuvant & Neoadjuvant Therapy for Lung CancerCaris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Charu Aggarwal, the Leslye M. Heisler Associate Professor for Lung Cancer Excellence at UPENN, and Dr. Balazs Halmos, Director, Thoracic Oncology at Montefiore. Together they discuss adjuvant and neoadjuvant therapy for resected non-small cell lung cancer (NSCLC). Topics discussed will include current treatment options, how treatment decision are made, and when treatment should be given.
For more information, please visit: www.CarisLifeSciences.com/POA-Intro/
2023-09-0132 min
Caris Molecular Minute PodcastsInterview with Dr. Salma Jabbour: A In-depth Look at the PROSPECT TrialCaris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Salma Jabbour, Clinical Chief, Radiation Oncology and Vice Chair of Clinical Research & Faculty Development at RWJUH/Rutgers Cancer Institute. Together they discuss a plenary presentation that was given at ASCO 2023 on rectal cancer titled, the PROSPECT (Preoperative Radiation or Selective Preoperative Radiation and Evaluation before Chemotherapy and TME) trial.
The PROSPECT trial attempts to challenge the current treatment paradigm by individualizing treatment through the use of radiotherapy selectively rather than reflexively. This is a randomized phase III trial of neoadjuvant chemoradiation versus neoadjuvant FOLFOX chemotherapy wi...2023-08-0921 min
The Natural State with Dr. Anthony Gustin181: Dr. Chadi Nabhan - The True Story Behind The Monsanto Cancer TrialsDr. Chadi Nabhan is an oncologist who testified as an expert witness in the first three litigation trials against Monsanto and their potentially cancer-causing herbicide Roundup. He chats with Dr. Anthony Gustin about all the “courtroom drama” and research he uncovered. Roundup is the most common weed killer in the world. Glyphosate (the active ingredient) taints our soil, waterways, and food — it’s even in 97% of people’s urine. Dr. Nabhan specializes in Non-Hodgkin’s Lymphoma, a disease in which malignant cancer cells form in the lymph system. He expl...2023-07-3158 min
The Courtenay Turner PodcastToxic Exposure & The Monsanto Trials w/ Dr. Chadi Nabhan | The Courtenay Turner PodcastIn this episode Courtenay invites to the show medical oncologist, author, and award-winning podcast host, Dr. Chadi Nabhan. Dr. Chadi was an expert witness in the first three litigation trials against Monsanto and the product Roundup. In his latest book, Toxic Exposure, he chronicles the story through his perspective backed with the unfiltered facts. This conversation is filled with invaluable information about existing toxins, the lack of informed consent to their consumption, and how to combat their harmful effects.Connect with Dr. Chadi:Website: https://chadinabhan.com/ Podcast: Healthcare UnfilteredBook: T...2023-07-271h 22
Caris Molecular Minute PodcastsInterview with Dr. Soma Sengupta: Advances in Glioblastoma Multiforme (GBM)
Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Soma Sengupta, the Harold C. Schott Endowed Brain Tumor Molecular Therapeutics Chair and Associate Professor of Clinicalat the University of Cincinnati. Together they explore the myriad of challenges in accurately diagnosing this aggressive brain tumor while examining the latest advancements in frontline treatment strategies.
For more information, please visit: www.CarisLifeSciences.com/POA-Intro/
2023-07-2023 min
Caris Molecular Minute PodcastsInterview with Dr. Stephen Liu: An In-depth Look at the ADAURA TrialCaris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Stephen Liu, Associate Professor of Medicine at Georgetown University and Director of Thoracic Oncology and Head of Developmental Therapeutics at the Georgetown Lombardi Comprehensive Cancer Center. Together they discuss the updated results of the ADAURA Trial presented at this year's ASCO meeting which demonstrated the overall survival benefit when adding osimertinib versus placebo in patients with completely resected stage IB-IIIA NSCLC, with/without adjuvant chemotherapy.
For more information, please visit: www.CarisLifeSciences.com/POA-Intro/
2023-07-1032 min
The Homegrown PodcastMonsanto Found GUILTY—behind the scenes of the Monsanto trials with oncologist and expert witness, Dr. Chadi NabhanIn this episode, we sat down the Dr. Chadi Nabhan to discuss the first three trials against Monsanto, all of which found Monsanto guilty of their link to the plaintiff's cancer. Dr. Chadi Nabhan is an award-winning hematologist and oncologist who served as an expert witness in the court cases against Monsanto, the manufacturer of Roundup and other herbicides. Tune in to hear the shocking details of the court cases linking glyphosate-based herbicides to cancer. Find Dr. Chadi NabhanBook // Toxic Exposure: The True Story Behind the Monsanto Trials and the Search fo...2023-07-051h 38
Integrative Cancer Solutions with Dr. KarlfeldtRevolutionizing Cancer Treatment: Integrative Solutions and AI in Medicine with Dr. Karlfeldt and Dr. Chadi NabhanLooking for a holistic and integrative approach to cancer treatment? Look no further than Integrative Cancer Solutions with Dr. Karlfeldt. In this week's episode, Dr. Karlfeltdt sits down with medical oncologist, podcaster, and author Dr. Chadi Nabhan to discuss the importance of integrative and holistic methods for cancer treatment. Together, they explore the potential of AI in medicine and how it can improve precision in medical diagnoses, ultimately leading to more personalized and effective cancer treatments. From the controversial history of Roundup weed killer to the importance of understanding the support system and values of a cancer patient, this...2023-06-2847 min
The joe gardener Show - Organic Gardening - Vegetable Gardening - Expert Garden Advice From Joe Lamp'l318-The True Story Behind the Monsanto Roundup Trials, with Dr. Chadi NabhanThough the International Agency for Research on Cancer concluded that glyphosate, the main ingredient in Roundup, is a probable carcinogen, it remains the most widely used herbicide in the United States. My guest this week, Dr. Chadi Nabhan is here to tell the story behind three court cases that concluded with Roundup maker Monsanto owing large sums to glyphosate users who developed non-Hodgkin lymphoma. Podcast Links for Show notes Download my free eBook 5 Steps to Your Best Garden Ever - the 5 most important steps anyone can do to have a thriving garden or landscape. It’s w...2023-06-221h 06
Myers Detox PodcastToxic Exposure: The Monsanto Roundup Trials with Dr. Chadi NabhanDr. Chadi Nabhan one of the lead doctors who testified during the Monsanto Roundup trials, and proved that glyphosate containing Roundup Ready weed killer does in fact cause non-Hodgkin's lymphoma, joins the show to talk about the trials and this alarming chemical. Dr. Nabhan gives us a first hand account of what it was like to testify in the trial, and some of the surprising things that happened during his time in court. He also goes over what non-Hodgkin’s lymphoma is, and the many other health issues Roundup may be contributing to. We also go over the political as...2023-06-1547 min
Caris Molecular Minute PodcastsInterview with Dr. Giselle Sholler: Pediatric Oncology and Precision MedicineCaris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Giselle Sholler, Director of the Isabella Santos Rare and Solid Tumor Program at the Levine Children’s Hospital, and Professor of Pediatrics and Principal Investigator of the Sholler Pediatric Oncology Research Laboratory. Together they discuss trends in managing pediatric hematologic cancers and how molecular profiling and genomic profiling intersect with clinical care.
For more information, please visit: www.CarisLifeSciences.com
2023-06-0720 min
EcoJustice RadioToxic Exposure: The Monsanto Roundup Trials & The Search For Justice with Dr. Chadi NabhanFor years, Monsanto declared that their product Roundup, the world's most widely used weed killer, was safe. But in 2015, scientific studies concluded that glyphosate, the active ingredient in Roundup, is probably carcinogenic. The Environmental Protection Agency (EPA) and Monsanto disagreed with the findings, as scientists worked to understand the link between glyphosate and cancer.
Dr. Chadi Nabhan's book, Toxic Exposure [https://chadinabhan.com/mybooks/], tells the true story of his role as an expert physician witness who testified in multiple state and federal trials against Monsanto. His book recounts the heartbreaking stories of numerous patients who developed the cancer non-Hodgkin...2023-06-051h 04
You Bet Your Garden’Fleabane’ The Misunderstood Pollinator Plant PLUS an interview with Author of TOXIC EXPOSURE Dr. Chadi NabhanOn this season capping episode of YBYG Mike fights the good fight with Monsanto Trial Expert Witness Dr. Chadi Nabhan! Plus in the Question of the week; Fleabane and its misbegotten misgivings!! Plus your fabulous phone calls!!!
2023-05-2059 min
Caris Molecular Minute PodcastsInterview with Dr. JJ Gao: AI, Machine Learning and Bioinformatics in Precision OncologyCaris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. JJ Gao, VP, Translational Informatics at Caris Life Sciences. Together they discuss his role in leading the Translational Informatics team at Caris Life Sciences and how artificial intelligence and bioinformatics is utilized to synthesize data to support cancer research and improve the outcomes of patients.
For more information, please visit: www.CarisLifeSciences.com2023-05-1525 min
Caris Molecular Minute PodcastsInterview with Dr. R. Donald Harvey: Pharmacovigilance and Pharmacoadherence
Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. R. Donald Harvey, Professor Department of Hematology and Medical Oncology at Emory University School of Medicine and Director of Winship Cancer Institute's Phase I Clinical Trials Unit. Together they discuss the role of the pharmacist in pharmacovigilance and pharmacoadherence, and how we can ensure that patients are being properly educated and compliant with the new products being approved each day.
For more information, please visit: www.CarisLifeSciences.com
2023-04-2623 min
Caris Molecular Minute PodcastsInterview with Dr. Nate Pennell: How Broad NGS Testing Can Save Lives and Potentially Reduce CostsCaris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Nate Pennell, Co-Director of the Cleveland Clinic Lung Cancer Program and Vice Chair of Clinical Research for the Taussig Cancer Institute. Together they discuss the methodology and results of a recent JCO paper for which Dr. Pennell was a senior author: Modeling Costs and Life-Years Gained by Population-Wide NGS or Single-Gene Testing in Nonsquamous Non–Small-Cell Lung Cancer in the US.
For more information, please visit: www.CarisLifeSciences.com
2023-04-1322 min
Caris Molecular Minute PodcastsInterview with Dr. Premal Thaker: Advances in GYN MalignanciesCaris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Premal Thaker, Professor of Obstetrics and Gynecology, and Director of Gynecological Oncology Clinical Research at the Washington University School of Medicine in Saint Louis. Together they discuss the advances in gynecological malignancies in the era of precision medicine, how they have impacted her practice, and how HRD (homologous recombination deficiency) is changing the way we treat patients today.
For more information, please visit: www.CarisLifeSciences.com
2023-03-2126 min
Caris Molecular Minute PodcastsInterview with Dr. Kristen Spencer: Top Abstracts from ASCO GI 2023Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Kristen Spencer, Assistant Professor, Department of Medicine and Director, Phase I Developmental Therapeutics Program at NYU Langone Perlmutter Cancer Center to discuss the latest findings and top abstracts presented at this year's ASCO GI meeting.
For more information, please visit: www.CarisLifeSciences.com2023-03-0728 min
The Sport of Life: Chats w/ Comedians, Filmmakers, Sports Figures, Musicians, & Intellectuals#315 - Dr. Chadi Nabhan on TOXIC EXPOSUREOncology and hematology expert Chadi Nabhan, MD, chats with Trey Elling about TOXIC EXPOSURE: THE TRUE STORY BEHIND THE MONSANTO TRIALS AND THE SEARCH FOR JUSTICE. Dr. Nabhan served as the expert witness on Non Hodgkin Lymphoma for plaintiffs in the first three cases against Monsanto and glyphosate, the primary ingredient in their Roundup herbicide. Topics include:
How Chadi’s medical training took focus on oncology and hematology (1:12)
Explaining Non-Hodgkin Lymphoma (4:23)
What made him want testify as an expert witness against Monsanto (5:59)
The shadiness behind glyphosate’s initial approval in 1974 (9:58)
The EPA’s role in glyphosate not being labele...2023-03-0249 min
the Essential Free Audiobooks in Non-Fiction, Current Affairs, Law, & PoliticsToxic Exposure: The True Story behind the Monsanto Trials and the Search for Justice by Chadi Nabhan Md Mba FacpPlease visit https://thebookvoice.com/podcasts/1/audiobook/646579 to listen full audiobooks. Title: Toxic Exposure: The True Story behind the Monsanto Trials and the Search for Justice Author: Chadi Nabhan Md Mba Facp Narrator: Chadi Nabhan Md Mba Facp Format: Unabridged Audiobook Length: 10 hours 39 minutes Release date: February 28, 2023 Ratings: Ratings of Book: 5 of Total 1 Genres: Current Affairs, Law, & Politics Publisher's Summary: For years, Monsanto declared that their product Roundup, the world’s most widely used weed killer, was safe. But that all changed in 2015, when the International Agency for Research on Cancer (IARC) analyzed data from scientific studies and concluded that gl...2023-02-2805 min
Grab the Essential Full Audiobooks in Non-Fiction, Current Affairs, Law, & PoliticsToxic Exposure: The True Story behind the Monsanto Trials and the Search for Justice by Chadi Nabhan Md Mba FacpPlease visithttps://thebookvoice.com/podcasts/1/audiobook/646579to listen full audiobooks.
Title: Toxic Exposure: The True Story behind the Monsanto Trials and the Search for Justice
Author: Chadi Nabhan Md Mba Facp
Narrator: Chadi Nabhan Md Mba Facp
Format: Unabridged Audiobook
Length: 10 hours 39 minutes
Release date: February 28, 2023
Ratings: Ratings of Book: 5 of Total 1
Genres: Current Affairs, Law, & Politics
Publisher's Summary:
For years, Monsanto declared that their product Roundup, the world’s most widely used weed killer, was safe. But that all changed in 2015, when the International Agency for Research on Cancer (IARC) analyzed data from scientific studies and concluded that glyphosate, th...2023-02-2810h 39
Caris Molecular Minute PodcastsInterview with Tiffany McConathy: Plea for Pediatric CancerCaris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down for an intimate discussion with Tiffany McConathy, nurse practitioner at Genesis Cancer and Blood Institute. Tiffany shares her family’s personal hardship of learning their eleven-month-old daughter Nora was diagnosed with embryonal tumor with multilayer rosettes (EMTR), a rare and untreatable form of pediatric brain cancer. Together, Chadi and Tiffany discuss Nora’s initial diagnosis, patient journey and the critical importance of dedicating research and resources to rare diseases such as EMTR.
For more information, please visit: www.CarisLifeSciences.com2023-02-0725 min
Caris Molecular Minute Podcast SeriesInterview with Tiffany McConathy: Plea for Pediatric CancerCaris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down for an intimate discussion with Tiffany McConathy, nurse practitioner at Genesis Cancer and Blood Institute. Tiffany shares her family’s personal hardship of learning their eleven-month-old daughter Nora was diagnosed with embryonal tumor with multilayer rosettes (EMTR), a rare and untreatable form of pediatric brain cancer. Together, Chadi and Tiffany discuss Nora’s initial diagnosis, patient journey and the critical importance of dedicating research and resources to rare diseases such as EMTR.
For more information, please visit: www.CarisLifeSciences.com2023-02-0225 min
Caris Molecular Minute PodcastsInterview with Dr. Bishoy Faltas: Advances in Bladder Cancer ResearchCaris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Bishoy Faltas, Assistant Professor of Medicine at Weill Cornell Medical College. Together they discuss bladder cancer, the evolution of the disease, and the latest research being conducted to improve the outcomes of patients.
For more information, please visit: www.CarisLifeSciences.com2023-01-0427 min
Caris Molecular Minute PodcastsInterview with Dr. Soo Park: Cutaneous Oncology and Precision MedicineCaris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Soo Park, Assistant Professor in the Division of Hematology-Oncology at UC San Diego Health. Together they discuss how precision medicine and molecular profiling have shaped the way we care for patients with cutaneous cancers.
For more information, please visit: www.CarisLifeSciences.com2022-12-1225 min
Caris Molecular Minute PodcastsInterview with Sarah Wyman & Kathryn Simon: Advance Practice Providers in Oncology CareCaris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Advance Practice Providers Kathryn Simon and Sarah Wyman from the Winship Cancer Institute at Emory University. Together they discuss the impact and contributions Advance Practice Providers make to oncology care in the era of precision medicine.
For more information, please visit: www.CarisLifeSciences.com2022-11-0228 min
Caris Molecular Minute PodcastsInterview with Dr. Milan Radovich: The Future of Precision OncologyCaris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Milan Radovich, Senior Vice President and Chief Precision Medicine Officer at Caris Life Sciences. Together they discuss the future of precision medicine, how precision oncology is evolving into the earlier stages of disease, and the paradigm shifts to look for in the overall survival of cancer.
For more information, please visit: www.CarisLifeSciences.com2022-10-0627 min
Caris Molecular Minute PodcastsInterview with Dr. Emil Lou: Liquid Biopsies in GI CancersCaris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Emil Lou, Associate Professor of Medicine in the Division of Hematology, Oncology and Transplantation at the University of Minnesota. Together they discuss the challenges in gastrointestinal cancer and how liquid biopsies are applied within these malignancies.
For more information, please visit: www.CarisLifeSciences.com2022-08-2428 min
Caris Molecular Minute PodcastsInterview with Dr. Elisabeth Heath: Liquid Biopsies in GU CancersCaris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Elisabeth Heath, Professor of Oncology and Associate Center Director, Translational Sciences, at Karmanos Cancer Institute. Together they discuss the advances and future of liquid biopsies and their clinical utilization within genitourinary cancers.
For more information, please visit: www.CarisLifeSciences.com2022-07-2821 min
Caris Molecular Minute PodcastsInterview with Dr. Stephen Liu: Liquid Biopsies in Thoracic CancersCaris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Stephen Liu, Associate Professor of Medicine at Georgetown University and Director of Thoracic Oncology at the Georgetown Lombardi Comprehensive Cancer Center. Together they discuss liquid biopsies and their utilization in thoracic malignancies.
For more information, please visit: www.CarisLifeSciences.com2022-06-2927 min
Caris Molecular Minute PodcastsInterview with Dr. David Spetzler: Advances in Liquid Biopsy OfferingsCaris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. David Spetzler, President and Chief Scientific Officer at Caris Life Sciences®, to discuss the latest advances in liquid biopsies, the clinical utility of these offerings, and how precision oncology is leveraging this new source of molecular information to improve patient outcomes.
For more information, please visit: www.CarisLifeSciences.com2022-06-2921 min
Caris Molecular Minute PodcastsInterview with Dr. Jimmy Hwang: Author to ASCO Provisional Opinion on Genomic TestingCaris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Jimmy Hwang, Chief, GI Medical Oncologist at the Levine Cancer Institute. Dr. Hwang recently contributed to a JCO publication titled, “Somatic Genomic Testing in Patients with Metastatic or Advanced Cancer: ASCO Provisional Clinical Opinion.” Together, Dr. Nabhan and Dr. Hwang discuss the recommendations made in this article and the impact genomic testing can have on patient outcomes.
For more information, please visit: www.CarisLifeSciences.com2022-05-2622 min
Caris Molecular Minute Podcast SeriesInterview with Dr. Jimmy Hwang: Author to ASCO Provisional Opinion on Genomic TestingCaris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Jimmy Hwang, Chief, GI Medical Oncologist at the Levine Cancer Institute. Dr. Hwang recently contributed to a JCO publication titled, “Somatic Genomic Testing in Patients with Metastatic or Advanced Cancer: ASCO Provisional Clinical Opinion.” Together, Dr. Nabhan and Dr. Hwang discuss the recommendations made in this article and the impact genomic testing can have on patient outcomes.
To access this article, please visit: https://ascopubs.org/doi/full/10.1200/JCO.21.02767
For more information, please visit: www.CarisLifeSciences.com2022-05-2622 min
Caris Molecular Minute PodcastsInterview with Dr. Jamie Holloway: Interpreting the Caris ReportCaris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Jamie Holloway, Area Vice President, Molecular Science Liaison at Caris Life Sciences. Together, they take a closer look at the Caris Report and explain how its results aid oncologists in personalizing cancer therapies for their patients.
For more information, please visit: www.CarisLifeSciences.com2022-05-0424 min
Caris Molecular Minute PodcastsInterview with Dr. Patricia Pittman: NeuropathologyCaris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Patricia Pittman, oncologic pathologist and neuropathologist at Caris Life Sciences, to discuss the latest in neuropathology.
For more information, please visit: www.CarisLifeSciences.com2022-04-1323 min
Caris Molecular Minute PodcastsInterview with Dr. Tian Zhang: Top abstracts from ASCO GU 2022Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Tian Zhang, Associate Professor at UT Southwestern Medical Center, to discuss the latest findings and top abstracts presented at this year's ASCO GU meeting.
For more information, please visit: www.CarisLifeSciences.com2022-03-0930 min
Caris Molecular Minute PodcastsInterview with Dr. Ben Weinberg: Top abstracts from ASCO GI 2022Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Ben Weinberg, Associate Professor of Medicine at Georgetown University, to discuss the latest findings and top abstracts presented at this year's ASCO GI meeting.
For more information, please visit: www.CarisLifeSciences.com2022-02-1130 min
Caris Molecular Minute PodcastsInterview with Dr. Salma Jabbour: Radiation OncologyCaris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Salma Jabbour, Clinical Chief of Radiation Oncology at Rutgers Cancer Institute. Together they discuss radiation oncology and its role in cancer care.
For more information, please visit: www.CarisLifeSciences.com2022-01-3124 min
Caris Molecular Minute PodcastsInterview with David Dubin: 3-time Cancer Survivor and Lynch Syndrome AdvocateCaris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with David Dubin, a 2-time colon cancer survivor, kidney cancer survivor, and third generation Lynch Syndrome carrier. Together they discuss his journey as a patient and how his foundation, Aliveandkickn.org, is helping to improve the lives of individuals and families affected by Lynch Syndrome.
For more information, please visit: www.CarisLifeSciences.com2021-11-0526 min
Caris Molecular Minute PodcastsInterview with Dr. Stephanie Graff: Advances in Breast CancerIn recognition of Breast Cancer Awareness Month, Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Stephanie Graff, Director of Breast Oncology at the Lifespan Cancer Institute at Brown University. Together they discuss the latest advances in breast cancer.
For more information, please visit: www.CarisLifeSciences.com2021-11-0521 min
The Rich Solution with Gwen RichThe Rich Solution - 20211020-Dr. Chadi Nabhan, "Communication In Cancer Care"Join Gwen Rich today at 10:00am CT on Mojo50 Radio during October Breast Cancer Awareness Month. My guest Dr. Chadi Nabhan @chadi_healthcareunfiltered, will speak on the topic of “Communication In Cancer Care”. The topic of communication is vital to patients. You’ll learn:1.How to communicate2.Different channels of communication with patients and families3.Advantages and pitfallsListen @ 10:00am CT on:www.mojo50.comiHeart RadioiTunesAppleLive streaming via:YouTube and Facebook:https://www.facebook.com/Therichsolution/https://www.youtube.com/c/therichsolution2021-10-2055 min
Caris Molecular Minute PodcastsInterview with Dr. Igor Astsaturov: Molecular Tumor BoardsCaris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Igor Astsaturov, Co-director of the Pancreatic Institute at Fox Chase Cancer Center and Chairman of the Caris Molecular Tumor Board. Together they discuss molecular tumor boards and how they are utilized at Caris and other academic sites.
For more information, please visit: www.CarisLifeSciences.com2021-09-2321 min
Caris Molecular Minute PodcastsInterview with Dr. Elisabeth Heath: Top abstracts in GU oncology from ASCO 2021Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Elisabeth Heath, Associate Center Director of Translational Sciences at Karmanos Cancer Institute. Together they discuss the latest findings and top abstracts in GU oncology that were presented at this year's ASCO meeting.
For more information, please visit: www.CarisLifeSciences.com2021-09-0224 min
Caris Molecular Minute PodcastsInterview with Dr. Charu Aggarwal: Top thoracic data and abstracts from ASCO 2021Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Charu Aggarwal, the Leslye Heisler Associate Professor of Medicine in the Hematology-Oncology Division at the University of Pennsylvania Perelman School of Medicine. Together they discuss the latest findings and top abstracts in thoracic oncology that were presented at this year's ASCO meeting.
For more information, please visit: www.CarisLifeSciences.com2021-08-2030 min
Caris Molecular Minute PodcastsInterview with Dr. Muhammad Shaalan Beg: A review of the top GI data and abstracts from ASCO 2021Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Muhammad Shaalan Beg, Director for Gastrointestinal (GI) Medical Oncology at UT Southwestern to discuss the latest findings and top abstracts in GI that were presented at this year's ASCO meeting.
For more information, please visit: www.CarisLifeSciences.com2021-08-1125 min
Caris Molecular Minute PodcastsInterview with Dr. Trisha Wise-Draper: Advances in head and neck cancersCaris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Trisha Wise-Draper, Associate Professor of Medicine in the Division of Hematology/Oncology at the University of Cincinnati. Together they discuss the latest advances in head and neck cancers as well as findings from this year's ASCO meeting.
For more information, please visit: www.CarisLifeSciences.com2021-08-1127 min
Caris Molecular Minute PodcastsInterview with Dr. Neeraj Agarwal: Genomic profiling and sequencing in GU malignanciesCaris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Neeraj Agarwal, Director of the Genitourinary Oncology Program at the Huntsman Cancer Institute. Together they discuss genomic profiling and sequencing in GU malignancies.
For more information, please visit: www.CarisLifeSciences.com2021-08-1126 min
Caris Molecular Minute PodcastsInterview with Dr. Sonikpreet Aulakh: The impact of precision oncology on brain tumorsCaris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Sonikpreet Aulakh, Assistant Professor of Medicine in translational neuro-oncology from West Virginia University, to discuss the impact of precision oncology on the treatment of brain tumors.
For more information, please visit: www.CarisLifeSciences.com2021-08-1126 min
Caris Molecular Minute PodcastsInterview with Dr. Heloisa Soares: Neuroendocrine tumors (NETs)Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Heloisa Soares, a medical oncologist at the Huntsman Cancer Institute (HCI) at the University of Utah. Together they discuss the latest treatments in neuroendocrine tumors (NETs) and the elements that allow us to understand the prognosis on both molecular and histopathology levels.2021-08-1123 min
Caris Molecular Minute PodcastsInterview with Dr. Olga Weinberg: Pediatric cancers and pediatric precision oncologyCaris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Olga Weinberg who is a hematopathologist and Director of Fellowship Education at UT Southwestern Medical Center. Together they discuss pediatric oncology and the applicability of NGS to these types of cancers.
For more information, please visit: www.CarisLifeSciences.com2021-08-1121 min
Caris Molecular Minute PodcastsInterview with Dr. Don Dizon: Genomic profiling and sequencing in GYN malignanciesCaris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Don Dizon, Director of Women's Cancers at Brown University's Lifespan Cancer Institute. Together they discuss precision oncology and the impact of genomic profiling and sequencing in the management of women with various gynecological malignancies.
For more information, please visit: www.CarisLifeSciences.com2021-08-1125 min
Caris Molecular Minute PodcastsInterview with Dr. Paolo Ascierto: Advances in immunotherapy and melanomaCaris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Paolo Ascierto, Director of the Unit of Melanoma and the Oncological Immunotherapy and Innovative Therapies Director at the National Tumor Institute “Fondazione G. Pascale”, in Naples, Italy. As the founder of both the Melanoma Bridge Meeting and the Immunotherapy Bridge Meeting, Dr. Ascierto shares outcomes from both meetings as well as insights into the latest treatments in both disease states.
For more information, please visit: www.CarisLifeSciences.com2021-08-1127 min
Caris Molecular Minute PodcastsInterview with Dr. Rana McKay: The latest findings from ASCO GU 2021Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Rana McKay, Associate Professor of Medicine from the University of California San Diego Health to discuss the latest findings and top abstracts presented at this year's virtual ASCO GU meeting.
For more information, please visit: www.CarisLifeSciences.com2021-08-1125 min
Caris Molecular Minute PodcastsInterview with Dr. Matthew Oberley: Genomic profiling and AI in cancers of unknown primary (CUP)Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Matthew Oberley, Executive Medical Director at Caris Life Sciences, to discuss how genomic profiling and AI are helping clinicians determine tumor origin for cancers of unknown primary (CUP) cases.
For more information, please visit: www.CarisLifeSciences.com2021-08-1123 min
Caris Molecular Minute PodcastsInterview with Dr. Emil Lou: Advances within GI oncologyCaris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Emil Lou, Associate Professor of Medicine in the Division of Hematology, Oncology and Transplantation at the University of Minnesota, to discuss the recent advances and future within GI oncology.
For more information, please visit: www.CarisLifeSciences.com2021-08-1131 min
Caris Molecular Minute PodcastsInterview with Dr. John Marshall and Dr. Tony Shields: MI FOLFOXai™Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. John Marshall, Chief, Division of Hematology/Oncology at Georgetown University, and Dr. Tony Shields, Associate Center Director, Clinical Sciences at Karmanos Cancer Center Institute. Both are co-authors on the December 8, 2020 paper: Clinical validation of a machine-learning derived signature predictive of outcomes from first-line oxaliplatin-based chemotherapy in advanced colorectal cancer found in Clinical Cancer Research, a journal of the American Association for Cancer Research.
In this interview Dr. Marshall and Dr. Shields discuss the findings of their paper and how we can better predict which metastatic co...2021-08-1127 min
Caris Molecular Minute PodcastsInterview with Dr. Marcus Neubauer: Precision oncology in community settingsCaris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Marcus Neubauer, Chief Medical Officer of the US Oncology Network, to discuss the challenges and opportunities of precision oncology in the community setting and how it is evolving.
For more information, please visit: www.CarisLifeSciences.com2021-08-1125 min
Caris Molecular Minute PodcastsInterview with Dr. Tian Zhang: Advances in prostate cancerCaris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Tian Zhang, Assistant Professor of Medicine at Duke University, to discuss the recent advances in prostate cancer and abstracts that were presented at this year's virtual ASCO meeting.
For more information, please visit: www.CarisLifeSciences.com2021-08-1129 min
Caris Molecular Minute PodcastsInterview with Dr. Virginia Kaklamani: Breast cancer and patient careCaris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Virginia Kaklamani from the University of Texas Health San Antonio, to discuss changes in the approach to both metastatic breast cancer and early stage breast cancer, and how these changes are impacting patient care.
For more information, please visit: www.CarisLifeSciences.com2021-08-1122 min
Caris Molecular Minute PodcastsInterview with patient advocate Laura Holmes HaddadCaris Precision Oncology Alliance™ Chairman Dr. Chadi Nabhan sits down with patient advocate Laura Holmes Haddad to discuss her personal journey with breast cancer and precision oncology.
For more information, please visit: www.CarisLifeSciences.com2021-08-1126 min
Caris Molecular Minute PodcastsInterview with Dr. Geoff Gibney: Evolving strategies in treating melanomaCaris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Geoff Gibney from Georgetown University to discuss evolving strategies in treating melanoma in the era of precision oncology.
For more information, please visit: www.CarisLifeSciences.com
oncologyprecisionmedicine2021-08-1131 min
Caris Molecular Minute PodcastsInterview with Dr. Michael Korn: MI FOLFOXai™Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Michael Korn, Chief Medical Officer at Caris Life Sciences®, to discuss the MI FOLFOXai™ predictor of response to FOLFOX chemotherapy in metastatic colorectal cancer.
For more information, please visit: www.CarisLifeSciences.com/MI-FOLFOXai/2021-08-1120 min
Caris Molecular Minute PodcastsInterview with Dr. Tian Zhang: Urothelial updates from ASCO 2020Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Tian Zhang, Assistant Professor of Medicine at Duke University to discuss the recent advances and data in urothelial cancer presented at this year's virtual ASCO meeting.
For more information, please visit: www.CarisLifeSciences.com2021-08-1127 min
Caris Molecular Minute PodcastsInterview with Dr. Stephen Liu: Lung cancer updates from ASCO 2020Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Stephen Liu from MedStar Georgetown University Hospital to discuss the latest lung cancer updates presented at this year's ASCO meeting.
For more information, please visit: www.CarisLifeSciences.com2021-08-1123 min
Caris Molecular Minute PodcastsInterview with President and Chief Scientific Officer of Caris Life Sciences - Dr. David Spetzler: Precision MedicineCaris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. David Spetzler, President and Chief Scientific Officer at Caris Life Sciences®, to discuss precision medicine.
For more information, please visit: www.CarisLifeSciences.com2021-08-1116 min
The Graft#7 Chadi Nabhan: good medicine, death, shame, science, public healthThe following is a conversation with Chadi Nabhan, Chairman of Precision Oncology Alliance at Caris Life Sciences. We talk with him about good medicine, the art of being human, actually caring for patients, and the essence of science and its abuse in current times of COVID. With his podcast "healthcare unfiltered", his perspective articles in Journal of Clinical Oncology, JAMA and others, he is a really human voice in an ever challenging environment of pretenders.
Previously, Dr. Nabhan was an Associate Professor of Medicine, and Medical Director of the Clinical Cancer Center at the University of Chicago...2021-07-121h 04
Beyond the Journal (Audio)Dr. Chadi Nabhan, on the Transition Between Academia and Industry, and the Appeal of Different Social Media Platforms to Discuss Timely Issues in Medicine | BTJ-016Hosts Jack West & Charu Aggarwal chat with Chadi Nabhan, oncologist & host of Healthcare Unfiltered, about the balance of medical talent between academia & industry, as well as the advantages of different social media platforms for thoughtful discussion.2021-06-0145 min
Beyond the JournalDr. Chadi Nabhan, on the Transition Between Academia and Industry, and the Appeal of Different Social Media Platforms to Discuss Timely Issues in Medicine | BTJ-016Hosts Jack West & Charu Aggarwal chat with Chadi Nabhan, oncologist & host of Healthcare Unfiltered, about the balance of medical talent between academia & industry, as well as the advantages of different social media platforms for thoughtful discussion.2021-06-0145 min
Healthcare UnfilteredCardiology, COVID-19, and College Sports: What Went WrongIn the inaugural episode of Healthcare Unfiltered, host Chadi Nabhan invites cardiologists Venk Murthy (@venkmurthy), MD, University of Michigan, and Anish Koka (@anish_koka), MD, private practice in Philadelphia, to contextualize the effects of COVID-19 on the heart, as explained in a flawed JAMA Cardiology publication that was close to having such trickle down effects as cancelling college sports across the US. The trio explains how the study should not be used to treat patients with preexisting cardiac conditions and COVID-19, the dangers of using the study as grounds for social policy, the importance of post-publication peer-review (via social media...2020-10-061h 09
West Wind (Video)Dr. Chadi Nabhan (Pt 2): Reflecting on Career Priorities, Struggling to Say No, & Defining a Place for Real World Evidence in Cancer TreatmentsDr. Chadi Nabhan & host Jack West consider the challenge of pruning career activities after struggling to define priorities & say no to opportunities; Dr. Nabhan reviews the value of real world evidence in evaluating cancer treatments.2019-06-2119 min
West Wind (Audio)Dr. Chadi Nabhan (Pt 2): Reflecting on Career Priorities, Struggling to Say No, & Defining a Place for Real World Evidence in Cancer TreatmentsDr. Chadi Nabhan & host Jack West consider the challenge of pruning career activities after struggling to define priorities & say no to opportunities; Dr. Nabhan reviews the value of real world evidence in evaluating cancer treatments.2019-06-2119 minThe BeaconDr. Chadi Nabhan (Pt 2): Reflecting on Career Priorities, Struggling to Say No, & Defining a Place for Real World Evidence in Cancer TreatmentsDr. Chadi Nabhan & host Jack West consider the challenge of pruning career activities after struggling to define priorities & say no to opportunities; Dr. Nabhan reviews the value of real world evidence in evaluating cancer treatments.2019-06-2100 min
The BeaconDr. Chadi Nabhan (Pt 2): Reflecting on Career Priorities, Struggling to Say No, & Defining a Place for Real World Evidence in Cancer TreatmentsDr. Chadi Nabhan & host Jack West consider the challenge of pruning career activities after struggling to define priorities & say no to opportunities; Dr. Nabhan reviews the value of real world evidence in evaluating cancer treatments.2019-06-2119 min
West Wind (Video)Dr. Chadi Nabhan (Pt 1): Reviewing the Path in a Medical Career from Clinic to the Business of Health CareDr. Chadi Nabhan speaks with host Jack West & reviews his circuitous course from medical training in Syria to lymphoma specialist & rising administrator in Chicago to his decision to pursue an MBA, leading him into a world of the business of health care.2019-06-1923 min
West Wind (Audio)Dr. Chadi Nabhan (Pt 1): Reviewing the Path in a Medical Career from Clinic to the Business of Health CareDr. Chadi Nabhan speaks with host Jack West & reviews his circuitous course from medical training in Syria to lymphoma specialist & rising administrator in Chicago to his decision to pursue an MBA, leading him into a world of the business of health care.2019-06-1923 minThe BeaconDr. Chadi Nabhan (Pt 1): Reviewing the Path in a Medical Career from Clinic to the Business of Health CareDr. Chadi Nabhan speaks with host Jack West & reviews his circuitous course from medical training in Syria to lymphoma specialist & rising administrator in Chicago to his decision to pursue an MBA, leading him into a world of the business of health care.2019-06-1900 min
The BeaconDr. Chadi Nabhan (Pt 1): Reviewing the Path in a Medical Career from Clinic to the Business of Health CareDr. Chadi Nabhan speaks with host Jack West & reviews his circuitous course from medical training in Syria to lymphoma specialist & rising administrator in Chicago to his decision to pursue an MBA, leading him into a world of the business of health care.2019-06-1923 min
Plenary Session - inactive due to federal service1.28 Questionable FDA Drug Approvals and Building a Career with Dr. Chadi NabhanIn this episode we critique two recent FDA drug approvals (venetoclax in combination with azacitidine or decitabine or low-dose cytarabine; glasdegib in combination with low-dose cytarabine -- both for acute myeloid leukemia)and we interview Dr. Chadi Nabhan, the Chief Medical Officer of Cardinal Health, on career transitions. The interview was taped on location at the 2018 annual conference of the American Society of Hematology in San Diego.2018-12-131h 04Plenary Session - inactive due to federal service1.28 Questionable FDA Drug Approvals and Building a Career with Dr. Chadi NabhanIn this episode we critique two recent FDA drug approvals (venetoclax in combination with azacitidine or decitabine or low-dose cytarabine; glasdegib in combination with low-dose cytarabine -- both for acute myeloid leukemia)and we interview Dr. Chadi Nabhan, the Chief Medical Officer of Cardinal Health, on career transitions. The interview was taped on location at the 2018 annual conference of the American Society of Hematology in San Diego.2018-12-131h 04